Brenden Schultek

Bio:

Brenden Schultek is the VP of Sales for Merz Therapeutics, where he is responsible for spearheading the strategic direction and Therapeutics sales strategy for the U.S.

Brenden has more than 20 years of strategic commercialization experience, spanning from large Fortune 50 to start-up organizations. Prior to joining Merz Therapeutics in 2024, Brenden was the VP of Strategic Growth at BioXcel Therapeutics, where he led the commercial market development strategy and sales force. Brenden began his career at Pfizer Pharmaceuticals before joining early-stage and start-up organizations, where he built sales functions from the ground up. His experience spans the commercial sphere, including analytics, field design, incentive compensation and market segmentation.

Brenden holds a Bachelor of Science in Finance and International Business from Villanova University. He lives in Wake Forest, North Carolina, with his wife and their two sons. When he can wake up early enough, Brenden enjoys training for long-distance triathlons.